Diasorin
DiaSorin S.p.A., headquartered in Italy, is a prominent player in the global diagnostics industry, specialising in the development and production of innovative diagnostic solutions. Founded in 1968, the company has established a strong presence in major operational regions, including Europe, North America, and Asia. With a focus on immunodiagnostics and molecular diagnostics, DiaSorin offers a range of unique products, including its LIAISON® and Simplexa™ platforms, which are renowned for their accuracy and efficiency. The company has achieved significant milestones, such as expanding its product portfolio and enhancing its technological capabilities, solidifying its market position as a leader in the field. Recognised for its commitment to quality and innovation, DiaSorin continues to advance healthcare diagnostics, making a meaningful impact on patient care worldwide.
DitchCarbon Score
How does Diasorin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Diasorin's score of 41 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Diasorin's reported carbon emissions
In 2023, Diasorin reported total carbon emissions of approximately 3,740,000 kg CO2e, comprising 85,000 kg CO2e from Scope 1, 18,000 kg CO2e from Scope 2, and 272,000 kg CO2e from Scope 3 emissions. This reflects a commitment to transparency in their emissions reporting across all scopes. The company has set an ambitious target to achieve Net Zero emissions by 2050, with this long-term goal encompassing all scopes of emissions. This commitment underscores Diasorin's dedication to sustainability and climate action, aligning with industry standards for reducing carbon footprints. In recent years, Diasorin has demonstrated a proactive approach to emissions management, with significant reductions noted in previous years. For instance, in 2021, the total emissions were about 13,038,000 kg CO2e, which indicates a positive trend towards lowering their carbon impact. Overall, Diasorin's climate commitments and reduction initiatives position the company as a responsible player in the healthcare sector, striving to mitigate its environmental impact while enhancing operational efficiency.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 617,530 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 9,489,510 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Diasorin is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
